Disease

Post Stroke Depression

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 3, 2026 · PHASE 2 TRIAL

Allopregnanolone (Zuranolone) in Post-stroke Depression

ClinicalTrials.gov

This is an ongoing Phase 2 trial registration with no posted results; the study is recruiting and designed to evaluate safety, tolerability, and efficacy of zuranolone in a very small population (n=6) with post-stroke depression.

PreliminaryPost Stroke Depression NCT06759558 Duke University

Reported

Planned enrollment6

Study phasePhase 2

Intervention dose50 mg zuranolone

JUL 31, 2026 · PHASE 4 TRIAL

A Study on the Preventive Effect of Electroacupuncture Combined With Dexmedetomidine in Post-stroke Depression

ClinicalTrials.gov

This is a clinical trial registration with no reported results; the study is not yet recruiting and outcome data are unavailable.

PreliminaryShame electropuncture Post Stroke Depression Min Su

Reported

Planned enrollment231

Primary outcome measureIncidence of PSD 3 months after stroke

Study phasePHASE4